Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.6912
+0.0468 (7.26%)
Oct 27, 2026, 4:00 PM EDT - Market closed
Milestone Pharmaceuticals Stock Forecast
MIST's stock price has decreased by -63.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Milestone Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $5.57. The average 1-year stock price forecast is 705.99% higher than the current stock price, while the lowest is $1.00 (+44.68%) and the highest is $8.00 (+1,057.41%).
Price Target: $5.57 (+705.99%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +623.38% | Oct 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +1,057.41% | Sep 22, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $3 | Buy | Initiates | $3 | +334.03% | Aug 20, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $8 | Buy | Maintains | $8 | +1,057.41% | Aug 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $7 | Buy | Maintains | $7 | +912.73% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
3.49M
from 1.55M
Increased by 125.44%
Revenue Next Year
19.61M
from 3.49M
Increased by 462.63%
EPS This Year
-0.84
from -0.75
EPS Next Year
-0.78
from -0.84
EPS and Forward PE are based on non-GAAP adjusted numbers.